Novel pyrimidine compound or salt thereof

Details for Australian Patent Application No. 2006209422 (hide)

International Classifications

Event Publications

23 August 2007 PCT application entered the National Phase

PCT publication WO2006/080509 Priority application(s): WO2006/080509

12 August 2010 Application Accepted

Published as AU-B-2006209422

9 September 2010 Application for Amendment

The nature of the amendment is: Amend the invention title to read Novel pyrimidine nucleoside compound or salt thereof. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

23 December 2010 Amendment Made

The nature of the amendment is: Amend the invention title to read Novel pyrimidine nucleoside compound or salt thereof 2006210791 Mallinckrodt Inc. The nature of the amendment is: Amend the invention title to read Bridgehead labelled compounds and methods of using the same

6 January 2011 Standard Patent Sealed

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.